Mycobacterial immunotherapy for prostate cancer: where can we go from here?

Stavrinides Vasilis; Dalgleish Angus; Copier John P.; Moore Caroline M.

首页> 外文期刊>Nature reviews. Urology >Mycobacterial immunotherapy for prostate cancer: where can we go from here?

【24h】

Mycobacterial immunotherapy for prostate cancer: where can we go from here?

机译：前列腺癌的分枝杆菌免疫疗法：我们可以从这里去哪里？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The effects of mycobacteria in prostate cancer have not been fully elucidated. Results of early studies indicated that mycobacterial immunotherapy conferred a survival benefit in patients with advanced prostate cancer, and recent evidence supports the safety and efficacy of new mycobacterial agents in many malignancies; thus, modern, carefully designed, randomized controlled trials of mycobacterial immunotherapy for prostate cancer could be warranted.

机译：分枝杆菌在前列腺癌中的影响尚未完全阐明。早期研究的结果表明，分枝杆菌免疫治疗赋予高级前列腺癌患者的生存效益，最近的证据支持许多恶性肿瘤新的分枝杆菌剂的安全性和疗效; 因此，可以保证现代，精心设计，随机对照试验，用于前列腺癌的分枝杆菌免疫疗法。

著录项

来源
《Nature reviews. Urology》 |2020年第4期|共2页
作者
Stavrinides Vasilis; Dalgleish Angus; Copier John P.; Moore Caroline M.;
展开▼
作者单位

UCL Div Surg &

Intervent Sci London England;

St Georges Univ London Inst Infect &

Immun Oncol Grp London England;

St Georges Univ London Inst Infect &

Immun Oncol Grp London England;

UCL Div Surg &

Intervent Sci London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Mycobacterial immunotherapy for prostate cancer: where can we go from here? [J] . Stavrinides Vasilis, Dalgleish Angus, Copier John P., Nature reviews. Urology . 2020,第4期

机译：前列腺癌的分枝杆菌免疫疗法：我们可以从这里去哪里？
2. Prostate Cancer in Focus: The Potential Role of Antigen Spread in Immunotherapy for Prostate Cancer [J] . Charles G. Drake Clinical advances in hematology & oncology: H&O . 2014,第5期

机译：聚焦前列腺癌：抗原在前列腺癌免疫治疗中的潜在作用
3. Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: A phase 1 dose-escalation trial [J] . VandenEertweghA.J.M., VersluisJ., VandenBergH.P., The lancet oncology . 2012,第5期

机译：转移性去势抵抗性前列腺癌患者的联合免疫疗法与粒细胞巨噬细胞集落刺激因子转导的异基因前列腺癌细胞和伊匹单抗的联合治疗
4. VACCINE BASED IMMUNOTHERAPY REGIMEN FOR THE TREATMENT OF PROSTATE CANCER [C] . Helen Cho Vaccine technology VI . 2016

机译：基于疫苗的免疫疗法用于前列腺癌的治疗
5. Targeting a self/tumor antigen expressed in the prostate for adoptive T cell immunotherapy of prostate cancer. [D] . Chou, Cassie K. 2012

机译：靶向前列腺中表达的自身/肿瘤抗原，用于前列腺癌的过继T细胞免疫疗法。
6. Prostate cancer immunotherapy particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance [O] . C. ALBERTI 2016

机译：前列腺癌免疫疗法特别是与雄激素剥夺或放射治疗相结合。定制的药物基因组学方法可克服免疫疗法对癌症的抵抗力
7. Mycobacterial immunotherapy for prostate cancer: where can we go from here? [O] . Vasilis Stavrinides, Angus Dalgleish, John P. Copier, 2020

机译：前列腺癌的分枝杆菌免疫治疗：我们可以从这里去哪里？
8. Immunotherapy of Prostate Cancer - Prostate Cancer Vaccine Clinical Trial [R] . Mincheff, M. 2004

机译：前列腺癌的免疫治疗 - 前列腺癌疫苗临床试验

Mycobacterial immunotherapy for prostate cancer: where can we go from here?

摘要

著录项

相似文献

相关主题

期刊订阅